Joshua M. Tarnoff
Chief Executive Officer at NephCure Kidney International, Inc.
Profile
Joshua M.
Tarnoff is currently the Chief Executive Officer at NephCure Kidney International, Inc. and also serves as a Director at Creegh Pharmaceuticals, Inc. He previously served as the Chief Executive Officer at HoustonPharma, Inc. and JDP Therapeutics LLC.
Prior to that, he was the President, Chief Executive Officer & Director at Complexa, Inc. from 2012 to 2018.
He also held marketing director positions at Astra Merck, Inc., AstraZeneca Pharmaceuticals LP, and Astra Pharmaceuticals, Inc. Additionally, he served as the Chief Commercial Officer & Vice President at Shire ViroPharma, Inc. Mr. Tarnoff received his undergraduate degree from LaSalle University.
Joshua M. Tarnoff active positions
| Companies | Position | Start |
|---|---|---|
NephCure Kidney International, Inc.
 NephCure Kidney International, Inc. Miscellaneous Commercial ServicesCommercial Services NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA. | Chief Executive Officer | 2018-03-05 |
Creegh Pharmaceuticals, Inc.
 Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Former positions of Joshua M. Tarnoff
| Companies | Position | End |
|---|---|---|
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Chief Executive Officer | 2018-05-13 |
JDP Therapeutics LLC
 JDP Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDP Therapeutics Inc. is a privately held, specialty pharmaceutical company focused on developing and commercializing proprietary product candidates for the treatment of life threatening diseases with significant unmet medical needs, principally for use in the hospital and urgent care settings. The company was founded by Jie Du in 2009 and is headquartered in Lansdale, PA. | Chief Executive Officer | - |
| Astra Pharmaceuticals, Inc. | Sales & Marketing | - |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Sales & Marketing | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Sales & Marketing | - |
Training of Joshua M. Tarnoff
| LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
HoustonPharma, Inc.
 HoustonPharma, Inc. Pharmaceuticals: MajorHealth Technology HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA. | Health Technology |
JDP Therapeutics LLC
JDP Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDP Therapeutics Inc. is a privately held, specialty pharmaceutical company focused on developing and commercializing proprietary product candidates for the treatment of life threatening diseases with significant unmet medical needs, principally for use in the hospital and urgent care settings. The company was founded by Jie Du in 2009 and is headquartered in Lansdale, PA. | Health Technology |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| Astra Pharmaceuticals, Inc. | |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
NephCure Kidney International, Inc.
NephCure Kidney International, Inc. Miscellaneous Commercial ServicesCommercial Services NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA. | Commercial Services |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Joshua M. Tarnoff
